Sign up to save your podcasts
Or
Share Vaccine Progress and What’s Next
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Vaccine Progress and What’s Next
Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Goldman Sachs
4.2
916916 ratings
Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Exchanges
View all
Bloomberg Intelligence
404 Listeners
Bloomberg Surveillance
1,172 Listeners
Masters in Business
2,179 Listeners
Odd Lots
1,960 Listeners
Notes on the Week Ahead
195 Listeners
Capital Allocators – Inside the Institutional Investment Industry
791 Listeners
Wall Street Breakfast
1,044 Listeners
UBS On-Air: Market Moves
185 Listeners
Making Sense
63 Listeners
Thoughts on the Market
1,299 Listeners
At Any Rate
77 Listeners
Barron's Streetwise
1,568 Listeners
The Memo by Howard Marks
446 Listeners
Barron's Live
210 Listeners
The Markets
79 Listeners